Literature DB >> 29728984

Correction to: Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers.

Lesley J Scott1.   

Abstract

An Online First version of this article was made available online at http://link.springer.com/journal/40265/onlineFirst/page/1 on 16 April 2018. Errors were subsequently identified in the article, and the following corrections should be noted.

Entities:  

Year:  2018        PMID： 29728984     DOI： 10.1007/s40265-018-0913-7

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


  8 in total

1.  Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells.

Authors:  Haijun Zhao; Yuelong Jiang; Fusheng Lin; Mengya Zhong; Jinshui Tan; Yong Zhou; Long Liu; Guowei Li; Manman Deng; Bing Xu
Journal:  Exp Hematol Oncol       Date:  2022-05-17

2.  Experimental study of the vascular normalization window for tumors treated with apatinib and the efficacy of sequential chemotherapy with apatinib in lung cancer-bearing mice and patients.

Authors:  Mingtao Liu; Hui Li; Xiuxiu Wang; Lijun Jing; Peng Jiang; Yu Li
Journal:  Cancer Med       Date:  2020-02-19       Impact factor: 4.452

3.  Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer.

Authors:  Jianzhao Chen; Lixia Feng; Qinghua Sheng; Lianna Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-13       Impact factor: 2.629

4.  A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Authors:  Tao Sun; Lei Chen; Xuefeng Kan; Yanqiao Ren; Yanyan Cao; Weihua Zhang; Haohao Lu; Chuansheng Zheng
Journal:  J Oncol       Date:  2022-03-21       Impact factor: 4.375

5.  Neoadjuvant apatinib plus tegafur/gimeracil/oteracil potassium (S‑1)/oxaliplatin chemotherapy vs. chemotherapy alone in patients with locally advanced gastric carcinoma.

Authors:  Zhenfeng Wang; Tingbang He; Deguo Yu; Xiantao Qin; Aizhi Geng; Hailei Yang
Journal:  Exp Ther Med       Date:  2022-08-17       Impact factor: 2.751

6.  Real-World Data on Apatinib Efficacy - Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment.

Authors:  Zhaoyun Liu; Jing Shan; Qian Yu; Xinzhao Wang; Xiang Song; Fukai Wang; Chao Li; Zhiyong Yu; Jinming Yu
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

7.  Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective study.

Authors:  Di Zhang; Chufeng Zhang; Jiaqi Huang; Yan Guan; Qisen Guo
Journal:  Thorac Cancer       Date:  2018-10-19       Impact factor: 3.500

8.  Preoperative neoadjuvant chemotherapy on surgical condition and oncogene expression in advanced gastric cancer.

Authors:  Guangyu Sun; Shuyan Wang; Guangsheng Liu
Journal:  Pak J Med Sci       Date:  2020 Mar-Apr       Impact factor: 1.088
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.